Mycotoxins and the kidney: Modes of action for renal tumor formation by ochratoxin A in rodents

Molecular Nutrition and Food Research

Volumn 53, Issue 4, 2009, Pages 467-478

  Mally, Angela ^a   Dekant, Wolfgang ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Carcinogenicity Kidney Mycotoxins Nephrotoxicity Ochratoxin A

Indexed keywords

DNA; MYCOTOXIN; OCHRATOXIN;

ANIMAL; APOPTOSIS; BIOTRANSFORMATION; CELL PROLIFERATION; CHEMICALLY INDUCED DISORDER; DNA ADDUCT; DRUG EFFECT; GENE EXPRESSION; KIDNEY TUMOR; METABOLISM; OXIDATIVE STRESS; RAT; REVIEW; RISK ASSESSMENT;

ANIMALS; APOPTOSIS; BIOTRANSFORMATION; CELL PROLIFERATION; DNA; DNA ADDUCTS; GENE EXPRESSION; KIDNEY NEOPLASMS; MYCOTOXINS; OCHRATOXINS; OXIDATIVE STRESS; RATS; RISK ASSESSMENT;

RODENTIA;

EID: 65749089980     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800149     Document Type: Review

References (95)

1. Grosman, M. E., Elias, M. M., Comin, E. J., Rodriguez Garay, E. A., Alterations in renal function induced by aflatoxin B1 in the rat, Toxicol. Appl. Pharmacol. 1983, 69, 319-325.
2. NTP, Toxicology and carcinogenesis studies of fumonisin B1 (cas no. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies), Natl. Toxicol. Program Tech. Rep. Ser. 2001, 1-352.
3. NTP, Toxicology and carcinogenesis studies of ochratoxin A (cas no. 303-47-9) in F344/N Rats (Gavage Studies), Natl. Toxicol. Program Tech. Rep. Ser. 1989, 358, 1-142.
4. Boorman, G. A., McDonald, M. R., Imoto, S., Persing, R., Renal lesions induced by ochratoxin A exposure in the F344 rat, Toxicol. Pathol. 1992, 20, 236-245.
5. Hard, G. C., Howard, P. C., Kovatch, R. M., Bucci, T. J., Rat kidney pathology induced by chronic exposure to fumonisin B1 includes rare variants of renal tubule tumor, Toxicol. Pathol. 2001, 29, 379 - 386.
6. JECFA, Safety evaluation of certain mycotoxins in food. Fifty-sixth meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), WHO Food Additives Series 2001, 47, 281-415.
7. Lock, E. A., Hard, G. C., Chemically induced renal tubule tumors in the laboratory rat and mouse: Review of the NCI/NTP database and categorization of renal carcinogens based on mechanistic information, Crit. Rev. Toxicol. 2004, 34, 211-299.
8. Li, J. J., Gonzalez, A., Banerjee, S., Banerjee, S. K., Li, S. A., Estrogen carcinogenesis in the hamster kidney: Role of cytotoxicity and cell proliferation, Environ. Health Perspect. 1993, 101 (Suppl. 5), 259 - 264.
9. Stevens, J. L., Jones, T. W., The role of damage and proliferation in renal carcinogenesis, Toxicol. Lett. 1990, 53, 121 - 126.
10. Dill, J. A., Lee, K. M., Renne, R. A., Miller, R. A., et al., Alpha 2u-globulin nephropathy and carcinogenicity following exposure to decalin (decahydronaphthalene) in F344/N rats, Toxicol. Sci. 2003, 72, 223 - 234.
11. Mally, A., Walker, C. L., Everitt, J. I., Dekant, W., Vamvakas, S., Analysis of renal cell transformation following exposure to trichloroethene in vivo and its metabolite S-(dichloro-vinyl)-L-cysteine in vitro, Toxicology 2006, 224, 108-118.
12. Peters, M. M., Jones, T. W., Monks, T. J., Lau, S. S., Cytotoxicity and cell-proliferation induced by the nephrocarcinogen hydroquinone and its nephrotoxic metabolite 2,3,5-(tris-glu-tathion-S-yl)hydroquinone, Carcinogenesis 1997, 18, 2393 - 2401.
13. Larson, J. L., Wolf, D. C., Butterworth, B. E., Acute hepatotoxic and nephrotoxic effects of chloroform in male F-344 rats and female B6C3F1 mice, Fundam. Appl. Toxicol. 1993, 20, 302-315.
14. Prescott-Mathews, J. S., Wolf, D. C., Wong, B. A., Borghoff, S. J., Methyl tert-butyl ether causes alpha2u-globulin nephropathy and enhanced renal cell proliferation in male Fischer-344 rats, Toxicol. Appl. Pharmacol. 1997, 143, 301-314.
15. Umemura, T., Takagi, A., Sai, K., Hasegawa, R., Kurokawa, Y., Oxidative DNA damage and cell proliferation in kidneys of male and female rats during 13-weeks exposure to potassium bromate (KBrO3), Arch. Toxicol. 1998, 72, 264 - 269.
16. Bolt, H. M., Foth, H., Hengstler, J. G., Degen, G. H., Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective, Toxicol. Lett. 2004, 151, 29-41.
17. Bolt, H. M., Degen, G. H., Human carcinogenic risk evaluation, part II: Contributions of the EUROTOX specialty section for carcinogenesis, Toxicol. Sci. 2004, 81, 3-6.
18. Krogh, P., Elling, F., Gyrd-Hansen, N., Hald, B., et al., Experimental porcine nephropathy: Changes of renal function and structure perorally induced by crystalline ochratoxin A, Acta Pathol. Microbiol. Scand. A 1976, 84, 429-434.
19. Krogh, P., Elling, F., Friis, C., Hald, B., et al., Porcine nephropathy induced by long-term ingestion of ochratoxin A, Vet. Pathol. 1979, 16, 466 - 475.
20. Stoev, S. D., Paskalev, M., MacDonald, S., Mantle, P. G., Experimental one year ochratoxin A toxicosis in pigs, Exp. Toxicol. Pathol. 2002, 53, 481 - 487.
21. Mally, A., Volkel, W., Amberg, A., Kurz, M., et al. Functional, biochemical, and pathological effects of repeated oral administration of ochratoxin A to rats, Chem. Res. Toxicol. 2005, 18, 1242 - 1252.
22. Maaroufi, K., Zakhama, A., Baudrimont, I., Achour, A., et al., Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats, Hum. Exp. Toxicol. 1999, 18, 410 - 415.
23. Rached, E., Hard, G. C., Blumbach, K., Weber, K., et al., Ochratoxin a: 13-Week oral toxicity and cell proliferation in male F344/N rats, Toxicol. Sci. 2007, 97, 288-298.
24. Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., et al., Aristolochic acid and the etiology of endemic (Balkan) nephropathy, Proc. Natl. Acad. Sci. USA 2007, 104, 12129 - 12134.
25. Arlt, V. M., Stiborova, M., vom Brocke, J., Simoes, M. L., et al., Aristolochic acid mutagenesis: Molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer, Carcinogenesis 2007, 28, 2253-2261.
26. Grollman, A. P., Jelakovic, B., Role of environmental toxins in endemic (Balkan) nephropathy. October 2006, Zagreb, Croatia, J. Am. Soc. Nephrol. 2007, 18, 2817-2823.
27. Zepnik, H., Volkel, W., Dekant, W., Toxicokinetics of the mycotoxin ochratoxin A in F 344 rats after oral administration, Toxicol. Appl. Pharmacol. 2003, 192, 36-44.
28. Zepnik, H., Pahler, A., Schauer, U., Dekant, W., Ochratoxin A-induced tumor formation: Is there a role of reactive ochratoxin A metabolites? Toxicol. Sci. 2001, 59, 59-67.
29. Calcutt, M. W., Gillman, I. G., Noftle, R. E., Manderville, R.A., Electrochemical oxidation of ochratoxin A: Correlation with 4-chlorophenol, Chem. Res. Toxicol. 2001, 14, 1266-1272.
30. Dai, J., Wright, M. W., Manderville, R. A., Ochratoxin a forms a carbon-bonded c8-deoxyguanosine nucleoside adduct: Implications for c8 reactivity by a phenolic radical, J.Am. Chem. Soc. 2003, 125, 3716 - 3717.
31. Dai, J., Park, G., Wright, M. W., Adams, M., et al., Detection and characterization of a glutathione conjugate of ochratoxin A, Chem. Res. Toxicol. 2002, 15, 1581 - 1588.
32. Follmann, W., Lucas, S., Effects of the mycotoxin ochratoxin A in a bacterial and a mammalian in vitro mutagenicity test system, Arch. Toxicol. 2003, 77, 298-304.
33. Wurgler, F. E., Friederich, U., Schlatter, J., Lack of mutagenicity of ochratoxin A and B, citrinin, patulin and cnestine in Salmonella typhimurium TA102, Mutat. Res. 1991, 261, 209-216.
34. Wehner, F. C., Thiel, P. G., van Rensburg, S. J., Demasius, I.P., Mutagenicity to Salmonella typhimurium of some Aspergillus and Penicillium mycotoxins, Mutat. Res. 1978, 58, 193-203.
35. Bendele, A. M., Neal, S. B., Oberly, T. J., Thompson, C. Z., et al., Evaluation of ochratoxin A for mutagenicity in a battery of bacterial and mammalian cell assays, Food Chem. Toxicol. 1985, 23, 911-918.
36. Obrecht-Pflumio, S., Chassat, T., Dirheimer, G., Marzin, D., Genotoxicity of ochratoxin A by Salmonella mutagenicity test after bioactivation by mouse kidney microsomes, Mutat. Res. 1999, 446, 95-102.
37. Hennig, A., Fink-Gremmels, J., Leistner, L., Mutagenicity and effects of ochratoxin A on the frequency of sister chromatid exchange after metabolic activation, IARC Sci. Publ. 1991, 255-260.
38. Greim, H. (Ed.), Gesundheitliche Arbeitsstoffe - Toxikologisch-arbeitsmedizinische Begr ndung von MAK-Werten, Senatskommission zur Pr fung gesundheitlicher Arbeits-stoffe der Deutschen Forschungsgemeinschaft, Wiley-VCH, 37. Lieferung 2003, in German.
39. Degen, G. H., Gerber, M. M., Obrecht-Pflumio, S., Dirheimer, G., Induction of micronuclei with ochratoxin A in ovine seminal vesicle cell cultures, Arch. Toxicol. 1997, 71, 365-371.
40. Ehrlich, V., Darroudi, F., Uhl, M., Steinkellner, H., et al., Genotoxic effects of ochratoxin A in human-derived hepatoma (HepG2) cells, Food Chem. Toxicol. 2002, 40, 1085 - 1090.
41. Dopp, E., Muller, J., Hahnel, C., Schiffmann, D., Induction of genotoxic effects and modulation of the intracellular calcium level in syrian hamster embryo (SHE) fibroblasts caused by ochratoxin A, Food Chem. Toxicol. 1999, 37, 713-721.
42. Lebrun, S., Follmann, W., Detection of ochratoxin A-induced DNA damage in MDCK cells by alkaline single cell gel electrophoresis (comet assay), Arch. Toxicol. 2002, 75, 734 - 741.
43. Follmann, W., Hillebrand, I. E., Creppy, E. E., Bolt, H. M., Sister chromatid exchange frequency in cultured isolated porcine urinary bladder epithelial cells (PUBEC) treated with ochratoxin A and alpha, Arch. Toxicol. 1995, 69, 280 - 286.
44. Mosesso, P., Cinelli, S., Pinero, J., Bellacima, R., Pepe, G., In vitro cytogenetic results supporting a DNA nonreactive mechanism for ochratoxin A, potentially relevant for its carcinogenicity, Chem. Res. Toxicol. 2008, in press, DOI: 10.1021/tx800029f.
45. Turesky, R. J., Perspective: Ochratoxin A is not a genotoxic carcinogen, Chem. Res. Toxicol. 2005, 18, 1082 - 1090.
46. Manderville, R. A., A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction, Chem. Res. Toxicol. 2005, 18, 1091 - 1097.
47. Mally, A., Dekant, W., DNA adduct formation by ochratoxin A: Review of the available evidence, Food Addit. Contam. 2005, 22, 65-74.
48. Pfohl-Leszkowicz, A., Grosse, Y., Kane, A., Creppy, E. E., Dirheimer, G., Differential DNA adduct formation and disappearance in three mouse tissues after treatment with the mycotoxin ochratoxin A, Mutat. Res. 1993, 289, 265 - 273.
49. Pfohl-Leszkowicz, A., Chakor, K., Creppy, E. E., Dirheimer, G., DNA adduct formation in mice treated with ochratoxin A, IARC Sci. Publ. 1991, 245 - 253.
50. Schlatter, C., Studer-Rohr, J., Rasonyi, T., Carcinogenicity and kinetic aspects of ochratoxin A, Food Addit. Contam. 1996, 13, 43-44.
51. Gautier, J., Richoz, J., Welti, D. H., Markovic, J., et al., Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes, Chem. Res. Toxicol. 2001, 14, 34-45.
52. Gross-Steinmeyer, K., Weymann, J., Hege, H. G., Metzler, M., Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin a in cultured rat and human primary hepatocytes, J. Agric. Food Chem. 2002, 50, 938-945.
53. Mally, A., Zepnik, H., Wanek, P., Eder, E., et al., Ochratoxin A: Lack of formation of covalent DNA adducts, Chem. Res. Toxicol. 2004, 17, 234 - 242.
54. Faucet, V., Pfohl-Leszkowicz, A., Dai, J., Castegnaro, M., Manderville, R. A., Evidence for covalent DNA adduction by ochratoxin A following chronic exposure to rat and subacute exposure to pig, Chem. Res. Toxicol. 2004, 17, 1289 - 1296.
55. Delatour, T., Mally, A., Richoz, J., Özden, S., et al., Absence of 29-deoxyguanosine-carbon 8-bound ochratoxin A adduct in rat kidney DNA monitored by isotope dilution LC-MS/MS, Mol. Nutr. Food Res. 2008, 52, 472-482.
56. Mally, A., Pepe, G., Ravoori, S., Fiore, M., et al., Ochratoxin A causes DNA damage and cytogenetic effects but no DNA adducts in rats, Chem. Res. Toxicol. 2005, 18, 1253-1261.
57. Palma, N., Cinelli, S., Sapora, O., Wilson, S. H., Dogliotti, E., Ochratoxin A-induced mutagenesis in mammalian cells is consistent with the production of oxidative stress, Chem. Res. Toxicol. 2007, 20, 1031 - 1037.
58. EFSA, Opinion of the scientific panel on contaminants in the food chain on a request from the commission related to ochratoxin A in food, EFSA-Q-2005-154, EFSA J. 2006, 365, 1-56.
59. Rahimtula, A. D., Bereziat, J. C., Bussacchini-Griot, V., Bartsch, H., Lipid peroxidation as a possible cause of ochratoxin A toxicity, Biochem Pharmacol. 1988, 37, 4469-4477.
60. Kamp, H. G., Eisenbrand, G., Janzowski, C., Kiossev, J. et al., Ochratoxin A induces oxidative DNA damage in liver and kidney after oral dosing to rats, Mol. Nutr. Food Res. 2005, 49, 1160-1167.
61. Gautier, J. C., Holzhaeuser, D., Markovic, J., Gremaud, E., et al., Oxidative damage and stress response from ochratoxin a exposure in rats, Free Radic. Biol. Med. 2001, 30, 1089 - 1098.
62. Domijan, A. M., Zeljezic, D., Kopjar, N., Peraica, M., Standard and Fpg-modified comet assay in kidney cells of ochratoxin A- and fumonisin B(1)-treated rats, Toxicology 2006, 222, 53-59.
63. Simarro Doorten, Y., Nijmeijer, S., de Nijs-Tjon, L., Fink-Gremmels, J., Metabolism-mediated Ochratoxin A genotoxicity in the single-cell gel electrophoresis (Comet) assay, Food Chem. Toxicol. 2006, 44, 261-270.
64. Arbillaga, L., Azqueta, A., Ezpeleta, O., Lopez de Cerain, A., Oxidative DNA damage induced by Ochratoxin A in the HK-2 human kidney cell line: Evidence of the relationship with cytotoxicity, Mutagenesis 2007, 22, 35-42.
65. Kamp, H. G., Eisenbrand, G., Schlatter, J., Wurth, K., Janzowski, C., Ochratoxin A: Induction of (oxidative) DNA damage, cytotoxicity and apoptosis in mammalian cell lines and primary cells, Toxicology 2005, 206, 413 - 425.
66. Arbillaga, L., Vettorazzi, A., Gil, A. G., Joost, H. M., et al., Gene expression changes induced by ochratoxin A in renal and hepatic tissues of male F344 rat after oral repeated administration, Toxicol. Appl. Pharmacol. 2008, 230, 197 - 207.
67. Omar, R. F., Hasinoff, B. B., Mejilla, F., Rahimtula, A. D., Mechanism of ochratoxin A stimulated lipid peroxidation, Biochem. Pharmacol. 1990, 40, 1183-1191.
68. Cavin, C., Delatour, T., Marin-Kuan, M., Holzhauser, D., et al., Reduction in antioxidant defences may contribute to ochratoxin A toxicity and carcinogenicity, Toxicol. Sci. 2007, 96, 30-39.
69. Marin-Kuan, M., Nestler, S., Verguet, C., Bezencon, C., et al., A Toxicogenomics approach to identify new Plausible Epigenetic Mechanisms of Ochratoxin A Carcinogenicity in Rat, Toxicol. Sci. 2006, 89, 120 - 134.
70. Rasonyi, T., Schlatter, J., Dietrich, D. R., The role of alpha2u-globulin in ochratoxin A induced renal toxicity and tumors in F344 rats, Toxicol. Lett. 1999, 104, 83-92.
71. Stemmer, K., Dietrich, D., Gender disparity in early ochratoxin A mediated renal toxicity, Toxicologist 2008, 102, 21.
72. Schulte-Hermann, R., Bursch, W., Grasl-Kraupp, B., Torok, L., et al., Role of active cell death (apoptosis) in multi-stage carcinogenesis, Toxicol. Lett. 1995, 82-83, 143-148.
73. Bayly, A. C., Roberts, R. A., Dive, C., Suppression of liver cell apoptosis in vitro by the nongenotoxic hepatocarcinogen and peroxisome proliferator nafenopin, J. Cell Biol. 1994, 125, 197-203.
74. Worner, W., Schrenk, D., Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1, Cancer Res. 1996, 56, 1272-1278.
75. James, N. H., Soames, A. R., Roberts, R. A., Suppression of hepatocyte apoptosis and induction of DNA synthesis by the rat and mouse hepatocarcinogen diethylhexylphlathate (DEHP) and the mouse hepatocarcinogen 1,4-dichlorobenzene (DCB), Arch. Toxicol. 1998, 72, 784-790.
76. Gekle, M., Schwerdt, G., Freudinger, R., Mildenberger, S., et al., Ochratoxin A induces JNK activation and apoptosis in MDCK-C7 cells at nanomolar concentrations, J. Pharmacol. Exp. Ther. 2000, 293, 837-844.
77. Sauvant, C., Holzinger, H., Gekle, M., Proximal tubular toxicity of ochratoxin A is amplified by simultaneous inhibition of the extracellular signal-regulated kinases 1/2, J. Pharmacol. Exp. Ther. 2005, 313, 234-241.
78. Schramek, H., Wilflingseder, D., Pollack, V., Freudinger, R. et al., Ochratoxin A-induced stimulation of extracellular signal-regulated kinases 1/2 is associated with Madin-Darby canine kidney-C7 cell dedifferentiation, J. Pharmacol. Exp. Ther. 1997, 283, 1460-1468.
79. Scibelli, A., Tafuri, S., Ferrante, M. C., Alimenti, E., et al., Ochratoxin A affects COS cell adhesion and signaling, Toxicol. Appl. Pharmacol. 2003, 192, 222-230.
80. Mally, A., Decker, M., Bekteshi, M., Dekant, W., Ochratoxin A alters cell adhesion and gap junction intercellular communication in MDCK cells, Toxicology 2006, 223, 15-25.
81. Horvath, A., Upham, B. L., Ganev, V., Trosko, J. E., Determination of the epigenetic effects of ochratoxin in a human kidney and a rat liver epithelial cell line, Toxicon 2002, 40, 273 - 282.
82. Petrik, J., Zanic-Grubisic, T., Barisic, K., Pepeljnjak, S., et al., Apoptosis and oxidative stress induced by ochratoxin A in rat kidney, Arch. Toxicol. 2003, 77, 685-693.
83. Sauvant, C., Holzinger, H., Gekle, M., The nephrotoxinochratoxin A induces key parameters of chronic interstitial nephropathy in renal proximal tubular cells, Cell Physiol. Biochem. 2005, 15, 125-134.
84. Rached, E., Pfeiffer, E., Dekant, W., Mally, A., Ochratoxin A: Apoptosis and aberrant exit from mitosis due to perturbation of microtubule dynamics? Toxicol. Sci. 2006, 92, 78-86.
85. Marin-Kuan, M., Nestler, S., Verguet, C., Bezencon, C., et al., MAPK-ERK activation in kidney of male rats chronically fed ochratoxin A at a dose causing a significant incidence of renal carcinoma, Toxicol. Appl. Pharmacol. 2007, 224, 174-181.
86. O'Brien, E., Heussner, A. H., Dietrich, D. R., Species-, sex and cell type-specific effects of ochratoxin A and B, Toxicol. Sci. 2001, 63, 256-264.
87. Luhe, A., Hildebrand, H., Bach, U., Dingermann, T., Ahr, H. J., A new approach to studying ochratoxin A (OTA)-induced nephrotoxicity: Expression profiling in vivo and in vitro employing cDNA microarrays, Toxicol. Sci. 2003, 73, 315-328.
88. Arbillaga, L., Azqueta, A., van Delft, J. H., Lopez de Cerain, A., In vitro gene expression data supporting a DNA nonreactive genotoxic mechanism for ochratoxin A, Toxicol. Appl. Pharmacol. 2007, 220, 216-224.
89. Hu, T., Gibson, D. P., Carr, G. J., Torontali, S. M., et al., Identification of a gene expression profile that discriminates indirect-acting genotoxins from direct-acting genotoxins, Mutat. Res. 2004, 549, 5-27.
90. Cavin, C., Delatour, T., Marin-Kuan, M., Holzhauser, D., et al., Reduction in antioxidant defenses may contribute to ochratoxin A toxicity and carcinogenicity, Toxicol. Sci. 2007, 96, 30-39.
91. Stemmer, K., Ellinger-Ziegelbauer, H., Ahr, H. J., Dietrich, D. R., Carcinogen-specific gene expression profiles in shortterm treated Eker and wild-type rats indicative of pathways involved in renal tumorigenesis, Cancer Res. 2007, 67, 4052-4068.
92. Hanahan, D., Weinberg, R. A., The hallmarks of cancer, Cell 2000, 100, 57-70.
93. Adler, M., Miller, K., Rached, E., Dekant, W., Mally, A., Aberrant expression of key regulators of mitosis and chromosome segregation in rat kidney following exposure to ochratoxin A, Toxicologist 2008, 102, 108.
94. Li, J. J., Li, S. A., Mitotic kinases: The key to dulication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis, Pharmacol. Ther. 2006, 111, 974-984.
95. Perez de Castro, I., de Carcer, G., Malumbres, M., A census of mitotic cancer genes: New insights into tumor cell biology and cancer therapy, Carcinogenesis 2007, 28, 899-912.